450 Eight weeks of creatine monohydrate supplementation is feasible and associated with increased brain creatine in patients with AD
Objectives/Goals: The creatine (Cr) system is impaired in Alzheimer’s disease (AD). Data show that creatine monohydrate (CrM) supplementation may improve AD symptoms in AD mouse models, but no human studies have been reported. Thus, we investigated whether an eight-week CrM supplementation was feasi...
Saved in:
| Main Authors: | Aaron Smith, Matthew Taylor, Choi In-Young, Phil Lee, Emma Kelly, Tanu Aroa, Faith Waitsman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2025-04-01
|
| Series: | Journal of Clinical and Translational Science |
| Online Access: | https://www.cambridge.org/core/product/identifier/S2059866124010471/type/journal_article |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Creatine monohydrate pilot in Alzheimer's: Feasibility, brain creatine, and cognition
by: Aaron N. Smith, et al.
Published: (2025-04-01) -
Creatine monohydrate supplementation for older adults and clinical populations
by: Darren G. Candow, et al.
Published: (2025-09-01) -
Histological Effects of Creatine Monohydrate Supplementation on Muscle Tissue in Wistar Rats
by: Isabela Ferreira Silveira ARRUDA, et al.
Published: (2023-06-01) -
Effects of 8-Week Creatine Supplementation With and Without Ubiquinol on Sperm Creatine Metabolism Biomarkers
by: David Nedeljkovic, et al.
Published: (2025-09-01) -
Properties and sensory acceptability of creatine-fortified foods using ultra-micronized creatine monohydrate – the KREAFOOD Project
by: Julián Quintero-Quiroz, et al.
Published: (2025-09-01)